We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IAG:LSEInternational Consolidated Airlines Group SA Analysis

Data as of 2026-09-01 - not real-time

£423.90

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind International Consolidated Airlines Group S.A. is neutral at £423.90, with no clear ordering between short and long averages. Over a rolling month the price has lost 3.2%. Momentum indicators put RSI at 41.7 (neutral) with MACD reading bullish. Price has been bracketed by support at £416.80 and resistance at £450.90.
The shares look undervalued, trading on 7.7 times earnings below a sector average of 28.8. Sell-side targets cluster 28.9% above the current quote. The 1.94% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 27.1%, a beta of 0.68 and a maximum drawdown of 25.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 8 out of 10.

Top Market Events

British Airways owner International Consolidated Airlines Group SA LSE:IAG and other European airline shares could have...British Airways owner International Consolidated Airlines Group SA LSE:IAG reported lower profits for the first half of...IAG delivers a robust first half with a 10.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Trading above the 200-day average of 413.71
  • MACD momentum is positive
  • Maximum drawdown of 25.1%

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 7.7 versus sector average of 28.8
  • Trading above the 200-day average of 413.71
  • Analyst targets imply +28.9% versus the current price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • P/E of 7.7 versus sector average of 28.8
  • Analyst targets imply +28.9% versus the current price
  • Return on equity of 42.1%

Key Metrics & Analysis

Financial Health

Revenue Growth0.20%
Profit Margin9.21%
P/E Ratio7.7
ROE42.14%
ROA6.96%
Debt/Equity160.66
P/B Ratio2.5
Op. Cash Flow£7.0B
Free Cash Flow£1.1B
Industry P/E28.8

Technical Analysis

TrendNeutral
RSI41.7
Support£416.80
Resistance£450.90
MA 20£436.10
MA 50£448.77
MA 200£413.71
MACDBullish
VolumeStable
Fear & Greed Index94.04

Valuation

Fair Value£212.12
Target Price£546.54
Upside/Downside28.93%
GradeUndervalued
TypeValue
Dividend Yield1.94%

Risk Assessment

Beta0.68
Volatility27.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.